{
    "nctId": "NCT05114005",
    "briefTitle": "Tango for Neuropathy Among Breast Cancer Survivors",
    "officialTitle": "Novel Interventions for Chemotherapy-Induced Neuropathy",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Cancer, Breast, Neuropathy",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 52,
    "primaryOutcomeMeasure": "Postural Control (variability)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Breast cancer survivor stage I-III\n* Symptomatic for neuropathy\n* postural control outside 70% CI for adults who are middle-aged without neurotrauma\n* having completed taxane-based chemotherapy treatment at least 3 months ago;\n* able to understand and comply with directions associated with testing and study treatments.\n\nExclusion Criteria:\n\n* Pre-existing vestibular deficit;\n* poorly controlled diabetes (hgA1C \\> 8);\n* non-ambulatory or lower extremity amputation (assistive devices allowed);\n* use of cytotoxic or immunotherapy during study (endocrine therapy allowed);\n* participation in physical therapy during the study;\n* contraindication to participate in Tango due to orthopedic issue (e.g., herniated vertebral disc);",
    "sex": "ALL",
    "minimumAge": "40 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}